Dr. Maja Travar

Department of Clinical Microbiology

University Clinical Center of Republic of Srpska

Banja Luka, Bosnia and Hercegovina

Topic of interest: Diagnostics and Laboratory research

BAVBD contribution:

Diagnostic (serology, molecular)

Relevant references:

1.       Serum Markers Associated with Disease Severity in a Bosnian Hemorrhagic Fever with Renal Syndrome Cohort. Viruses 2022-06-24.DOI: 10.3390/v14071377 

2.       Antimicrobial resistance profiles of human Brucella melitensis isolates in three different microdilution broths: the first multicentre study in Bosnia and Herzegovina. Journal of Global Antimicrobial Resistance. DOI: 10.1016/j.jgar.2022.02.005

3.       Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization. Molecular and Cellular Biochemistry 2021  DOI: 10.1007/s11010-020-03981-7

4.       Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studiesBioorganic Chemistry. 2021 | journal-article DOI: 10.1016/j.bioorg.2021.105145

5.        SARS-CoV-2 virus outbreak and the emergency public health measures in Bosnia and Herzegovina: January – July, 2020Bosnian Journal of Basic Medical Sciences. DOI: 10.17305/bjbms.2020.5081

6.       Characteristics and outcomes of critically ill patients with influenza A (H1N1) in the Western Balkans during the 2019 post-pandemic season. Indian Journal of Medical Microbiology 2020 | journal-article DOI: 10.4103/ijmm.IJMM_20_169 

7.       Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Eurosurveillance 2020 | journal-article DOI: 10.2807/1560-7917.ES.2020.25.45.2001735

 8.       Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: Lessons learned to optimize future molecular and epidemiological approaches. bioRxiv 2020 | other DOI: 10.1101/2020.06.19.160606